Andere Sprachen Neuronetics, Inc.

Aktien

A2JPMY

US64131A1051

STIM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 06.09.2024			% 5 Tage	% 1. Jan.
0,7750 ^USD	-1,03 %		-12,24 %	-73,28 %

12.08.	Neuronetics-Aktien fallen nach unter den Erwartungen liegenden Q2-Ergebnissen und Fusionsankündigung	MT
12.08.	Transcript : Neuronetics, Inc., Q2 2024 Earnings Call, Aug 12, 2024

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories	03.09.
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories	03.09.
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University	20.08.
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University	20.08.
Neuronetics Shares Slump as Q2 Results Fall Below Estimates; Merger Announcement	12.08.
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	12.08.
Neuronetics: Q2 Earnings Snapshot	12.08.
Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.5M, vs. Street Est of $18.7M	12.08.
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge	12.08.
Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results	12.08.
Neuronetics, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024	12.08.
Neuronetics, Inc. entered into a definitive arrangement agreement to acquire Greenbrook TMS Inc. (OTCPK:GBNH.F) from Madryn Health Partners II (Cayman Feeder), LP, fund managed by Madryn Asset Management, LP and others for $1 million.	12.08.
Neuronetics Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	06.08.
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	05.08.
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month	01.08.
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference	31.07.
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors	30.07.
Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call	29.07.
Neuronetics, Inc. - Aetna Policy Update Expands TMS Availability for Adolescents with Depression	23.07.
Aetna Policy Update Expands TMS Availability for Adolescents With Depression	22.07.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Neuronetics, Inc.

Aktien

A2JPMY

US64131A1051

STIM

Andere Sprachen

Filter